1-237456575-ATTT-ATTTTT
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP6_Very_StrongBA1
The NM_001035.3(RYR2):c.1477-12_1477-11dupTT variant causes a intron change involving the alteration of a non-conserved nucleotide. Variant has been reported in ClinVar as Likely benign (★★). There are indicators that this mutation may affect the branch point..
Frequency
Genomes: 𝑓 0.011 ( 40 hom., cov: 0)
Exomes 𝑓: 0.0093 ( 2 hom. )
Consequence
RYR2
NM_001035.3 intron
NM_001035.3 intron
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 1.43
Genes affected
RYR2 (HGNC:10484): (ryanodine receptor 2) This gene encodes a ryanodine receptor found in cardiac muscle sarcoplasmic reticulum. The encoded protein is one of the components of a calcium channel, composed of a tetramer of the ryanodine receptor proteins and a tetramer of FK506 binding protein 1B proteins, that supplies calcium to cardiac muscle. Mutations in this gene are associated with stress-induced polymorphic ventricular tachycardia and arrhythmogenic right ventricular dysplasia. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -16 ACMG points.
BP6
Variant 1-237456575-A-ATT is Benign according to our data. Variant chr1-237456575-A-ATT is described in ClinVar as [Likely_benign]. Clinvar id is 1204240.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.0924 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RYR2 | ENST00000366574.7 | c.1477-25_1477-24insTT | intron_variant | Intron 15 of 104 | 1 | NM_001035.3 | ENSP00000355533.2 | |||
RYR2 | ENST00000609119.2 | n.1477-25_1477-24insTT | intron_variant | Intron 15 of 103 | 5 | ENSP00000499659.2 | ||||
RYR2 | ENST00000660292.2 | c.1477-25_1477-24insTT | intron_variant | Intron 15 of 105 | ENSP00000499787.2 | |||||
RYR2 | ENST00000659194.3 | c.1477-25_1477-24insTT | intron_variant | Intron 15 of 104 | ENSP00000499653.3 |
Frequencies
GnomAD3 genomes AF: 0.0106 AC: 1585AN: 149082Hom.: 40 Cov.: 0
GnomAD3 genomes
AF:
AC:
1585
AN:
149082
Hom.:
Cov.:
0
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.00932 AC: 11267AN: 1209390Hom.: 2 Cov.: 0 AF XY: 0.00946 AC XY: 5585AN XY: 590404
GnomAD4 exome
AF:
AC:
11267
AN:
1209390
Hom.:
Cov.:
0
AF XY:
AC XY:
5585
AN XY:
590404
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0106 AC: 1583AN: 149164Hom.: 40 Cov.: 0 AF XY: 0.0116 AC XY: 841AN XY: 72574
GnomAD4 genome
AF:
AC:
1583
AN:
149164
Hom.:
Cov.:
0
AF XY:
AC XY:
841
AN XY:
72574
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:1
Aug 06, 2022
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing
- -
not provided Benign:1
Aug 16, 2019
GeneDx
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BranchPoint Hunter
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at